Nausheen Ahmed

27PUBLICATIONS
183CO-AUTHORS
Liquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursHaematologyNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 18, 2026
TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers.

|Apr 14, 2026
Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study.

Doris K Hansen, Danai Dima, Hira Mian

|Jul 24, 2025
Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysis.

Nausheen Ahmed, Swetha Kambhampati Thiruvengadam, Mehdi Hamadani

|Jul 07, 2025
Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis.

Miguel-Angel Perales, Farrukh T Awan, Ariane Boumendil

|Jun 04, 2025
Global Access to Multiple Myeloma Therapies.

|May 05, 2025
Attitudes and perspectives of oncologists about measurable residual disease testing in multiple myeloma: initiative for standardizing guidelines.

Aqeeb Ur Rehman, Fathima Shehnaz Ayoobkhan, Moazzam Shahzad

Pageof 5

Frequent Collaborators

11 joint publications

Joseph P McGurik

6 joint publications

Mehdi Hamadani

5 joint publications

Faiz Anwer

4 joint publications

Mazyar Shadman